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Clinics 
Age and sex: 28 years old female patient. 
Previous History: 
- no preleukemia; 
- no previous malignant disease; 
- no inborn condition of note. 
Organomegaly: 
- no hepatomegaly; 
- no splenomegaly; 
- no enlarged lymph nodes; 





Immunophenotype: Positive for CD13, CD33 and 
CD117 
Rearranged Ig or Tcr: - 
Pathology: MPO and SBB negative 
Precise diagnosis: AML-M0 (FAB) 
Survival 
Date of diagnosis: 03-2007. 
Treatment: 7+3 protocol (7 days of cytosine 
arabinoside continuous infusion + 3 doses of 
Daunorubicin), patient did not respond. Hence, she was
treated with high dose of cytosine arabinoside together 
with etoposide; however, she didn't respond. In view of 
poor prognosis, she was discharged on 25/03/2007 and 
died on 26/03/2007. 
Complete remission: none 
Treatment related death: - 
Relapse: - 
Status: Dead 
Survival: 1 month 
Karyotype 
Sample: Bone marrow 
Culture time: 24/48h 
Banding: G-banding 
Results: 46,XX,t(11;20)(p15;q11) [100%, 24/24 cell]. 
Other molecular cytogenetic techniques: FISH with 
WCP probes for chromosome 11. 
Other molecular cytogenetics results: Three spots of 11 
in interphase cells. Due to low mitotic index 
metaphases could not be spotted. No more material 
could be tested for NUP98 and TOP1 fusion. 
Comments 
Chromosomal rearrangement between 11p15 and 
20q11 has been reported in hematologic malignancies 
(Lam and Aplan, 2001), which results in fusion of the 
nucleoporin gene, NUP98 on chromosome 11p15 with 
topoisomerase 1, TOP1 gene located at 20q11. The 
NUP98 is a member of nuclear pore complex and 
involved in nuclear-cytosolic transport of RNA and 
protein complexes, and TOP1 is a protein whose c-
terminus site of active tyrosine forms phosphodiester 
bond with 3'-strand of DNA and generates transient 
single strand DNA breaks (Wang 2002). In t(11;20), 
the rearrangement generates NUP98-TOP1 fusion 
protein from fusion of N-terminal portion of NUP98 (1- 
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G-banding shows t(11;20)(p15;q11); Interphase FISH with three signals of chromosome 11. 
 
514) with most of TOP1 gene (170-765), including 
core, linker and catalytic domains (Gurevich et al. 
2004). It has been suggested that the NUP98-TOP1 has 
leukemogenic activities independent of topoisomerase 
activity. The t(11;20) has also been described in 
patients with polycythemia vera, T-MDS and acute 
myeloid leukemia (Chen et al. 2003, Potenza et al. 
2004, Panagopoulos et al. 2002). Our case aged 28 
years with 60 kg weight has been reported with AML-
M0 and probable NUP98 and TOP1 fusion. In addition, 
del(3p), inv(X) and der(7) was observed in one single 
cell. Short survival of 2.5 - 30 months was reported 
after diagnosis (Sekikawa and Horiguchi-yamada, 
2005). Our patient got the shortest survival of 23 days 
after diagnosis  
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